Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 17/20 | 0.66 |
| ▸ | CSF1R | P07333 | 1/20 | 0.46 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4941878 | 0.94 | HRH3 (0.73) | HRH3CSF1RKCNH2 | |
| SCHEMBL3722065 | 0.94 | HRH3 (0.73) | HRH3CSF1RKCNH2 | |
| SCHEMBL3720942 | 0.93 | HRH3 (0.65) | HRH3CSF1RKCNH2 | |
| SCHEMBL3726164 | 0.88 | HRH3 (0.68) | HRH3KCNH2LMNAHTT | |
| SCHEMBL4937192 | 0.88 | HRH3 (0.65) | HRH3CSF1RKCNH2LMNAHTT | |
| SCHEMBL3728789 | 0.85 | HRH3 (0.66) | HRH3KCNH2 | |
| SCHEMBL3726628 | 0.85 | HRH3 (0.73) | HRH3CSF1RKCNH2LMNAHTT | |
| SCHEMBL4945899 | 0.85 | HRH3 (0.73) | HRH3CSF1RKCNH2LMNAHTT | |
| SCHEMBL3666533 | 0.84 | HRH3 (0.90) | HRH3KCNH2 | |
| SCHEMBL4943231 | 0.83 | HRH3 (0.90) | HRH3KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080293771-A1 | AZACYCLYLBENZAMIDE DERIVATIVES AS HISTAMINE-3 ANTAGONISTS | WYETH (US) | 2008-11-27 | — | — | US | claimed |
| US-20080293771-A1 | AZACYCLYLBENZAMIDE DERIVATIVES AS HISTAMINE-3 ANTAGONISTS | WYETH (US) | 2008-11-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080293771-A1 | AZACYCLYLBENZAMIDE DERIVATIVES AS HISTAMINE-3 ANTAGONISTS | HRH4, HRH3, HRH2 | HRH3 2/4885CSF1R 947/4885KCNH2 581/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.